➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Colorcon
McKesson
McKinsey
AstraZeneca

Last Updated: January 17, 2021

DrugPatentWatch Database Preview

Certolizumab pegol - Biologic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for certolizumab pegol

Identify potential brand extensions & biosimilar entrants

SponsorPhase
UCB Biopharma SRLPhase 3
RenJi HospitalN/A
UCB Biopharma S.P.R.L.Phase 1

See all certolizumab pegol clinical trials

Recent Litigation for certolizumab pegol

Identify key patents and potential future biosimilar entrants

PTAB Litigation
PetitionerDate
2017-12-20

See all certolizumab pegol litigation

Pharmacology for certolizumab pegol

Patent Text Search: US Patents for certolizumab pegol

These patents were identified by searching patent claims

Supplementary Protection Certificates for certolizumab pegol

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2020 00011 Denmark   Start Trial PRODUCT NAME: UPADACITINIB; REG. NO/DATE: EU/1/19/1404 20191218
20C/505 Belgium   Start Trial PRODUCT NAME: UPADACITINIB OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; AUTHORISATION NUMBER AND DATE: EU/1/19/1404 20191218
2020000000022 Italy   Start Trial PRODUCT NAME: UPADACITINIB IN QUALSIASI FORMA PROTETTA DAL BREVETTO DI BASE(RINVOQ); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/19/1404, 20191218
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Harvard Business School
Medtronic
Dow
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.